Dementia and Aging
*You must be registered for the ANA2021 Virtual Annual Meeting to access the live SIG Series sessions.
Date/Time ET: Friday, November 19, 2021 - 11:30 AM – 1:00 PM
Session Title: Network Biology
Description: Cognitive decline is among the most feared complications of aging. Understanding the drivers of late life cognitive decline, particularly those that result in dementia, is of critical importance to our aging population. The Dementia and Aging SIG brings together experts in the fields of cognitive aging and dementia to discuss progress, challenges, and paths forward. This year's edition of the Dementia and Aging SIG will focus on network biology and novel genetic, transcriptomic, and epigenetic approaches to understanding dementia susceptibility and progression.
Chair: Jasmeer Chhatwal, MD, PhD, MMSc, Massachusetts General Hospital, Harvard Medical School
Co-Chair: Thomas Wingo, MD, Emory University, School of Medicine
- Understand the breadth of current network approaches to analyzing -omic data
- Understand how these approaches are being used in unique ways to ask questions about the biology
Combined Molecular and Imaging Approaches to Alzheimer's Mechanisms
Christopher Gaiteri, PhD
Rush University, Medical Center
Bernard Ng, Rush University Medical Center; University of British Columbia
Abeta-accelerated Neurodegeneration Caused by Alzheimer’s-associated ACE Variant R1279Q is Rescued by Angiotensin System Inhibit
Characterizing the Role of Genetic Variants Influencing α-synuclein Seeding Activity Neuropathologically Quantified Human Brains
Naveen Kondru, DVM, PhD
Functional Genomics Approach to Neuronal-Glial Mechanisms of Neurodegeneration
Jessica Rexach MD, PhD
UCLA Geffen School of Medicine
Epigenetic Pathways in Healthy Aging and Neurodegeneration
Raffaela Nativio, PhD
Imperial College London
Continuing Medical Education
The American Neurological Association hosts a wide range of educational programs. These programs seek to enhance the development and success of those pursuing a career in academic neurology at all levels. There are educational offerings to benefit those at the beginning stages of their careers, including students and those in their first faculty position, as well as those looking for best practices in Chair level positions. These programs seek to enhance attendee success in the field of academic neurology and to contribute to the overall education of neurologists and neuroscientists.
The Special Interest Groups offer CME to eligible participants. Click here to see a complete breakdown of how many credits are available per session.
ACCME Accreditation, AMA Designation, and MIPS Statements **Pertaining to Each Session Awarding CME**
The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Neurological Association designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
Instructions For Obtaining CME
Following the event, the evaluation and credit claiming system will open in OnDEC. Please complete the online evaluation by 12/31/2021 to obtain CME credit. You will be provided with a certificate after completing the evaluation. If you have any questions, please contact the ANA Meeting Coordinator at: email@example.com.
Click here to see a complete breakdown of how many credits are available per session.
Financial Disclosure Statements
The planners and faculty for this activity do not have any relationships to disclose unless listed here. Any relevant relationships with ACCME-defined ineligible companies will be mitigated according to ACCME Standards prior to the start of the activity.
Disclosure of Commercial Support
ANA received educational grants from the following ACCME-defined ineligible companies to support the CME aspects of this event: Added as confirmed.
DISCLAIMER: The ANA does not endorse or affiliate with third-party companies, products or services including those that may have elected to support the Special Interest Groups.